Asset transfer and license agreement termination notice period if bankruptcy petition filed.

No definition available.

Name:	etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled
Namespace Prefix:	etnb_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset transfer and license agreement termination period after written notice.

+ References

No definition available.

+ Details

Name:	etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice
Namespace Prefix:	etnb_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset transfer and license agreement termination period notice of failure.

+ References

No definition available.

+ Details

Name:	etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure
Namespace Prefix:	etnb_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Milestone payment.

+ References

No definition available.

+ Details

Name:	etnb_MilestonePayment
Namespace Prefix:	etnb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Obligation to payment upon maximum achievement of certain clinical and commercial milestones.

+ References

No definition available.

+ Details

Name:	etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
Namespace Prefix:	etnb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Operating lease expiration month and year.

+ References

No definition available.

+ Details

Name:	etnb_OperatingLeaseExpirationMonthAndYear
Namespace Prefix:	etnb_
Data Type:	xbrli:gYearMonthItemType
Balance Type:	na
Period Type:	duration

- Definition

Operating lease liability percentage.

+ References

No definition available.

+ Details

Name:	etnb_OperatingLeaseLiabilityPercentage
Namespace Prefix:	etnb_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

No definition available.

+ Details

Name:	us-gaap_LeaseAndRentalExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980

+ Details

Name:	us-gaap_LesseeOperatingLeaseRemainingLeaseTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasGlycoPEGylatedFGF21ProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasDevelopmentProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=etnb_SanFranciscoOfficeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Additional Information (Details) - USD ($)			1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 31, 2022	Jan. 01, 2022	Apr. 30, 2018	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Loss Contingencies [Line Items]
Operating leases, rent expense				$ 47,000	$ 70,000	$ 100,000	$ 200,000
Remaining lease term				2 years 3 months 18 days		2 years 3 months 18 days
Incremental borrowing rate used to determine operating lease liability percentage						6.50%
Teva Agreement
Loss Contingencies [Line Items]
Payment upon achievement of certain clinical and commercial milestones			$ 135,000,000.0
Asset transfer and license agreement, termination period after written notice						120 days
Asset transfer and license agreement, termination period notice of breach						60 days
Asset transfer and license agreement termination notice period if bankruptcy petition filed						60 days
Teva Agreement \| Research and Development Expenses
Loss Contingencies [Line Items]
Milestone payments				$ 0	$ 0	$ 0	$ 0
Teva Agreement \| Teva's GlycoPEGylated FGF21 Program
Loss Contingencies [Line Items]
Payment upon achievement of certain clinical and commercial milestones			67,500,000
Teva Agreement \| Teva's Development Program
Loss Contingencies [Line Items]
Payment upon achievement of certain clinical and commercial milestones			$ 67,500,000
San Francisco Office
Loss Contingencies [Line Items]
Operating lease expiration month and year	2025-01	2023-01